Finance

Lists
RPID:NASDAQ
Rapid Micro Biosystems, Inc
$0.98
+0.13%
(+0.0013) 1D
Oct 6, 11:56:04 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RPID...
Open
$1.00
High
$1.00
Low
$0.95
Mkt. cap
46.04M
Avg. vol.
298.26K
Volume
88.71K
52-wk high
$4.94
52-wk low
$0.86
EPS
-$1.11
Beta
1.50
Shares outstanding
45.66M
No. of employees
171
Open
$1.00
High
$1.00
Low
$0.95
Mkt. cap
46.04M
Avg. vol.
298.26K
Volume
88.71K
52-wk high
$4.94
52-wk low
$0.86
EPS
-$1.11
Beta
1.50
Shares outstanding
45.66M
No. of employees
171
News stories
From web sources and news partners
About Rapid Micro Biosystems, Inc
CEO-
Employees171
Founded2006
HeadquartersLowell, Massachusetts, United States
SectorHealth care
Websiterapidmicrobio.com
Analyst ratings
Based on 3 analysts giving stock ratings to RPID in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for RPID in the last 3 months.
Highest
Current $0.98
$8.00 (+718.25%)
Average
$6.00 (+513.69%)
Lowest
$3.00 (+206.84%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Buy
Initiated
$3.00
+206.8%
09/29/2026
Thomas Flaten
Lake Street
Buy
Maintained
$7.00
+616%
08/10/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$8.00
+718.2%
08/10/2026
Paul Knight
KeyBanc
Buy
Maintained
$5.00
+411.4%
05/29/2026
Brendan Smith
TD Cowen
Buy
Maintained
-
-
05/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.84M
11.28M
8.00M
8.05M
Cost of goods sold
7.14M
11.61M
7.63M
6.84M
Cost of revenue
7.14M
11.61M
7.63M
6.84M
Research and development expenses
3.53M
3.22M
3.36M
3.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.54M
8.66M
10.86M
10.20M
Operating expense
12.07M
11.88M
14.22M
13.53M
Total operating expenses
19.21M
23.49M
21.85M
20.38M
Operating income
-11.37M
-12.21M
-13.85M
-12.32M
Other non operating income
-79.00K
80.00K
-32.00K
-50.00K
EBT including unusual items
-11.50M
-12.48M
-14.27M
-12.88M
EBT excluding unusual items
-11.50M
-12.48M
-14.27M
-12.88M
Income tax expense
8.00K
14.00K
8.00K
45.00K
Effective tax rate
-0.07%
-0.11%
-0.06%
-0.35%
Other operating expenses
-
-
-
-
Net income
-11.50M
-12.50M
-14.28M
-12.92M
Net profit margin
-146.78%
-110.77%
-178.39%
-160.45%
Earnings per share
-0.26
-0.28
-0.31
-0.27
Interest and investment income
347.00K
321.00K
256.00K
140.00K
Interest expense
-393.00K
-673.00K
-639.00K
-646.00K
Net interest expenses
-46.00K
-352.00K
-383.00K
-506.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.67M
-11.62M
-13.15M
-11.65M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps